PHX 1149,* a novel dipeptidyl peptidase IV inhibitor, improves glycaemic control for patients with type 2 diabetes mellitus,

&NA;

doi:10.2165/00128413-200715780-00027

PHX 1149,* a novel dipeptidyl peptidase IV inhibitor, improves glycaemic control for patients with type 2 diabetes mellitus,

Inpharma Weekly ◽

10.2165/00128413-200715780-00027 ◽

2007 ◽

Vol &NA; (1578) ◽

pp. 10

Author(s):

&NA;

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Glycaemic Control ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase Iv

Download Full-text

Association between HbA1c and dipeptidyl peptidase IV activity in type 2 diabetes mellitus

Clinica Chimica Acta ◽

10.1016/j.cca.2012.02.021 ◽

2012 ◽

Vol 413 (11-12) ◽

pp. 1020-1021 ◽

Cited By ~ 5

Author(s):

Luziane Potrich Bellé ◽

Paula Eliete Rodrigues Bitencourt ◽

Karine Santos De Bona ◽

Rafael Noal Moresco ◽

Maria Beatriz Moretto

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase Iv

Download Full-text

Glucagon-like peptide 1 and inhibitors of dipeptidyl peptidase IV in the treatment of type 2 diabetes mellitus

Current Opinion in Pharmacology ◽

10.1016/j.coph.2004.08.005 ◽

2004 ◽

Vol 4 (6) ◽

pp. 589-596 ◽

Cited By ~ 87

Author(s):

Jens Juul Holst ◽

Carolyn F Deacon

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase Iv ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Vildagliptin (LAF 237): A Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes Mellitus

Journal of Pharmacy Technology ◽

10.1177/875512250602200207 ◽

2006 ◽

Vol 22 (2) ◽

pp. 105-109 ◽

Cited By ~ 1

Author(s):

Susan Cornell

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase Iv

Download Full-text

The dipeptidyl peptidase-IV inhibitor PSN 9301* is effective in reducing blood glucose levels in patients with type 2 diabetes mellitus,

Inpharma Weekly ◽

10.2165/00128413-200515180-00019 ◽

2005 ◽

Vol &NA; (1518) ◽

pp. 9

Author(s):

&NA;

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Blood Glucose ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase Iv ◽

Glucose Levels ◽

Blood Glucose Levels

Download Full-text

Incretin Mimetics and Dipeptidyl Peptidase-IV Inhibitors: Potential New Therapies for Type 2 Diabetes Mellitus

Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ◽

10.1592/phco.26.3.360 ◽

2006 ◽

Vol 26 (3) ◽

pp. 360-374 ◽

Cited By ~ 23

Author(s):

Curtis Triplitt ◽

Alison Wright ◽

Elaine Chiquette

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase Iv ◽

Incretin Mimetics ◽

New Therapies ◽

Dipeptidyl Peptidase Iv Inhibitors

Download Full-text

Early and Chronic Dipeptidyl‐Peptidase‐IV Inhibition and Cardiovascular Events in Patients With Type 2 Diabetes Mellitus After an Acute Coronary Syndrome: A Landmark Analysis of the EXAMINE Trial

Journal of the American Heart Association ◽

10.1161/jaha.117.007649 ◽

2018 ◽

Vol 7 (11) ◽

Cited By ~ 5

Author(s):

Abhinav Sharma ◽

Christopher P. Cannon ◽

William B. White ◽

Yuyin Liu ◽

George L. Bakris ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Acute Coronary Syndrome ◽

Cardiovascular Events ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase Iv ◽

Coronary Syndrome ◽

Dipeptidyl Peptidase Iv Inhibition

Download Full-text

To investigate the efficacy of dipeptidyl peptidase-IV (DPP-IV) inhibitor therapy in multiethnic Asian patients with type 2 diabetes mellitus

Diabetes Research and Clinical Practice ◽

10.1016/s0168-8227(16)31232-3 ◽

2016 ◽

Vol 120 ◽

pp. S123-S124

Author(s):

Julia Andres ◽

Jia Xuan Yeo ◽

Chin Meng Khoo

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase Iv ◽

Inhibitor Therapy ◽

Asian Patients ◽

Dpp Iv

Download Full-text

The effect of dipeptidyl peptidase-IV inhibition on circulating T cell subpopulations in patients with type 2 diabetes mellitus

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2016.06.020 ◽

2016 ◽

Vol 118 ◽

pp. 183-192 ◽

Cited By ~ 15

Author(s):

Lucie Sromova ◽

Petr Busek ◽

Helena Posova ◽

Jana Potockova ◽

Pavel Skrha ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

T Cell ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase Iv ◽

Cell Subpopulations ◽

Dipeptidyl Peptidase Iv Inhibition ◽

T Cell Subpopulations

Download Full-text

Serum Levels of Soluble CD26/Dipeptidyl Peptidase-IV in Type 2 Diabetes Mellitus and Its Association with Metabolic Syndrome and Therapy with Antidiabetic Agents in Malaysian Subjects

PLoS ONE ◽

10.1371/journal.pone.0140618 ◽

2015 ◽

Vol 10 (10) ◽

pp. e0140618 ◽

Cited By ~ 12

Author(s):

Radwan H. Ahmed ◽

Hasniza Zaman Huri ◽

Zaid Al-Hamodi ◽

Sameer D. Salem ◽

Sekaran Muniandy

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Metabolic Syndrome ◽

Type 2 Diabetes Mellitus ◽

Serum Levels ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase Iv ◽

Antidiabetic Agents

Download Full-text

Use of dipeptidyl peptidase IV inhibitor in the comprehensive management of type 2 diabetes mellitus in Chinese population

Scientia Sinica Vitae ◽

10.1360/n052018-00124 ◽

2018 ◽

Vol 48 (8) ◽

pp. 926-934

Author(s):

JuMing LU

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Chinese Population ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase Iv ◽

Comprehensive Management

Download Full-text